close
MENU
Shoeshine
5 mins to read

Ebos tortoise claims a big win

Analysis: Australian pharmaceuticals distribution is low margin, highly competitive and heavily regulated.

Fri, 06 Jul 2018

Shoeshine has often mused about what makes a great business story and it’s almost always when a company goes off the rails and produces appalling results.

Like the famous tortoise, slow and steady so often wins the business race, but it seldom produces great headlines.

Shoeshine has joked

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Ebos tortoise claims a big win
Shoeshine,
75668
true